This patent covers synthetic oligonucleotides (composition of matter) derived from promoter of gamma globulin, which stimulate erthrocytic differentiation.
The patent is useful for treatment of patients post chemotherapy increase hemoglobin counts, and also for development of in vitro erythrocyte culture systems. The mechanism by which these oligonucleotides work appears unclear.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.